Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2005, Vol. 105, No. 2, pp. 711-720.
Prepublished online as a Blood First Edition Paper on September 2, 2004; DOI 10.1182/blood-2004-03-0842.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-03-0842v1
105/2/711    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Musikacharoen, T.
Right arrow Articles by Matsuguchi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Musikacharoen, T.
Right arrow Articles by Matsuguchi, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted March 5, 2004
Accepted August 26, 2004

Interleukin-15 induces IL-12 receptor {beta}1 gene expression through PU.1 and IRF 3 by targeting chromatin remodeling

Tipayaratn Musikacharoen, Asako Oguma, Yasunobu Yoshikai, Norika Chiba, Akio Masuda, and Tetsuya Matsuguchi*

Department of Developmental Medicine, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan
Division of Host Defense, Center for Neural Disease and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan
Division of Host Defense, Research Center of Prevention of Infectious Diseases, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan

* Corresponding author; email: tmatsugu{at}denta.hal.kagoshima-u.ac.jp.

Interleukin-12 receptor {beta}1 (IL-12R{beta}1) is expressed on a variety of immune cells including T/NK cells and macrophages, and involved in both innate and adaptive immune responses. Levels of IL-12R{beta}1 mRNA are dynamically regulated by various cytokines including interferon-{gamma}(IFN-{gamma}) and IL-15. To reveal the regulatory mechanisms governing IL-12R{beta}1 gene expression, we analyzed the transcriptional regulatory region of the mouse IL-12R{beta}1 gene. Promoter analyses in a mouse macrophage cell line, RAW264.7, revealed that the 2508bp region upstream of the transcriptional start site is sufficient for the full transcriptional activation of the IL-12R{beta}1 gene by either IFN-{gamma} or IL-15. Analyses of the deletion mutants revealed critical roles of IRE/ISRE and ETS/PU.1 elements, to which IRF3 and PU.1 respectively bound. Notably, chromatin immunoprecipitation (ChIP) assays revealed IL-15 rapidly induced histone H3 acetylation at the IL-12R{beta}1 promoter. Consistently, IL-15, like a histone deacetylase inhibitor, synergistically enhanced IL-12R{beta}1 gene expression and promoter activation by IFN-{gamma} through increased protein binding to both ETS/PU.1 and IRE/ISRE sites. Additionally, IL-12R{beta}1 promoter activation by IFN-{gamma} was enhanced by the co-expression of a co-activator protein, CBP. Thus IL-15 induces chromatin remodeling of the IL-12R{beta}1 gene promoter increasing IL-12R{beta}1 mRNA expression in synergy with IFN-{gamma} through recruitment of PU.1 and IRF3.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Nutr.Home page
H. Mizubuchi, T. Yajima, N. Aoi, T. Tomita, and Y. Yoshikai
Isomalto-Oligosaccharides Polarize Th1-Like Responses in Intestinal and Systemic Immunity in Mice
J. Nutr., December 1, 2005; 135(12): 2857 - 2861.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020